Key result
Archon1 improves signal-to-noise ratio ~52% over Di-8-ANEPPS in hiPSC-derived cardiomyocytes.
Why the study?
Voltage-sensitive dyes prevent chronic imaging, while current genetically encoded voltage indicators in cardiac tissue exhibit poor kinetics and/or low signal-to-noise ratio.
Does the genetically encoded voltage sensor Archon1 enable precise measurement of action potentials in hiPSC-derived cardiomyocytes compared to traditional methods?
Does the genetically encoded voltage sensor Archon1 enable precise measurement of action potentials in hiPSC-derived cardiomyocytes compared to traditional methods?
Archon1 provides a high-fidelity, genetically encoded method for long-term voltage imaging in cardiac cells and 3D tissues, overcoming limitations of traditional dyes.
May improve voltage imaging fidelity in cardiac cell models; leaves open clinical translation pending validation.
Precise measurement of action potentials (APs) is needed to observe electrical activity and cellular communication within cardiac tissue. Voltage-sensitive dyes (VSDs) are traditionally used to measure cardiac APs; however, they require acute chemical addition that prevents chronic imaging. Genetically encoded voltage indicators (GEVIs) enable long-term studies of APs without the need of chemical additions, but current GEVIs used in cardiac tissue exhibit poor kinetics and/or low signal to noise (SNR). Here, we demonstrate the use of Archon1, a recently developed GEVI, in hiPSC-derived cardiomyocytes (CMs). When expressed in CMs, Archon1 demonstrated fast kinetics comparable with patch-clamp electrophysiology and high SNR significantly greater than the VSD Di-8-ANEPPS. Additionally, Archon1 enabled monitoring of APs across multiple cells simultaneously in 3D cardiac tissues. These results highlight Archon1's capability to investigate the electrical activity of CMs in a variety of applications and its potential to probe functionally complex in vitro models, as well as in vivo systems.
No takes yet. Share an insight, caveat, or question.
Shroff et al. (2020) studied this question. Archon1 vs. Di-8-ANEPPS and patch-clamp electrophysiology was evaluated on Signal-to-noise ratio (SNR) (p=4.87 x 10^-8). Archon1 expression in hiPSC-derived cardiomyocytes demonstrated fast kinetics and a significantly higher signal-to-noise ratio (30.7 vs 20.2) compared to the voltage-sensitive dye Di-8-ANEPPS.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: